Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

CAPS Rating: 2 out of 5

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

Recs

0
Player Avatar Fiskhus (72.87) Submitted: 4/28/2011 10:33:06 PM : Outperform Start Price: $7.88 NBIX Score: -14.53

T11A MB9

Featured Broker Partners


Advertisement